SPRY icon

ARS Pharmaceuticals
SPRY

Overview Fund Activity

73 hedge funds and large institutions have $425M invested in ARS Pharmaceuticals in 2022 Q4 according to their latest regulatory filings, with 25 funds opening new positions, 25 increasing their positions, 13 reducing their positions, and 13 closing their positions.

Holders
73
Holders Change
+12
Holders Change %
+19.67%
% of All Funds
1.18%
Holding in Top 10
3
Holding in Top 10 Change
+2
Holding in Top 10 Change %
+200%
% of All Funds
0.05%
New
25
Increased
25
Reduced
13
Closed
13
Calls
$6.79M
Puts
–
Net Calls
+$6.79M
Net Calls Change
+$3.92M

Top Buyers

1
DM
1
Deerfield Management
New York
$94.5M
2
RCM
2
RA Capital Management
Massachusetts
$25.7M
3
SOCM
3
SR One Capital Management
Pennsylvania
$25.7M
4
BBA
4
Baker Bros. Advisors
New York
$17.1M
5
Fidelity Investments
5
Fidelity Investments
Massachusetts
$45.8M

Top Sellers

1
NCM
1
Nantahala Capital Management
Connecticut
$0
2
KPF
2
K2 Principal Fund
Ontario, Canada
$24.5M
3
Millennium Management
3
Millennium Management
New York
$270K
4
SAM
4
Sectoral Asset Management
Quebec, Canada
$6.67M
5
Jacobs Levy Equity Management
5
Jacobs Levy Equity Management
New Jersey
$2.55M
Name Holding Trade Value Shares
Change 		Shares
Change %
T. Rowe Price Associates
76
T. Rowe Price Associates
Maryland
– -$140K -26,500 Closed
State of Wisconsin Investment Board
77
State of Wisconsin Investment Board
Wisconsin
– -$128K -24,200 Closed
OQS
78
Occudo Quantitative Strategies
Florida
– -$80K -15,057 Closed
AC
79
Apogem Capital
New York
– -$73K -13,793 Closed
QFA
80
Quattro Financial Advisors
Texas
– -$68K -12,869 Closed
TSS
81
Two Sigma Securities
New York
– -$67K -12,740 Closed
SSA
82
Schonfeld Strategic Advisors
New York
– -$62K -11,600 Closed
Federated Hermes
83
Federated Hermes
Pennsylvania
– -$12K -2,220 Closed
BNP Paribas Financial Markets
84
BNP Paribas Financial Markets
France
– -$2.41K -456 Closed
1 2 3
4